REC Interventional Cardiology最新文献

{"title":"Safety and efficacy profile of excimer laser coronary angioplasty for thrombus removal in STEMI.","authors":"Mohsen Mohandes, Alberto Pernigotti, Mauricio Torres, Cristina Moreno, Humberto Coimbra, Roberto Bejarano, Jordi Guarinos, Francisco Fernández, José Luis Ferreiro","doi":"10.24875/RECICE.M25000537","DOIUrl":"10.24875/RECICE.M25000537","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Thrombus removal in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) can be challenging in the presence of a large thrombus burden. Excimer laser coronary angioplasty (ELCA) is an adjuvant device capable of vaporizing thrombus. This study aimed to evaluate the safety and efficacy profile of ELCA in PCI.</p><p><strong>Methods: </strong>Patients with STEMI undergoing PCI with concomitant use of ELCA for thrombus removal were retrospectively identified at our center. Data were collected on the device efficacy and its contribution to overall procedural success. Additionally, ELCA-related complications and major adverse cardiovascular events were recorded at a 2-year follow-up.</p><p><strong>Results: </strong>ELCA was used in 130 STEMI patients, 124 (95.4%) of whom had a large thrombus burden. TIMI grade flow improved significantly after ELCA: before laser application, TIMI grade-0 flow was reported in 79 (60.8%) cases and TIMI grade-1 flow in 32 (24.6%) cases. After ELCA, TIMI grade-2 and 3 flows were achieved in 45 (34.6%) and 66 (50.8%) cases, respectively (<i>P</i> < .001). Technical and procedural success were achieved in 128 (98.5%) and 124 (95.4%) cases, respectively. The complications included 1 death at the cath lab (0.8%), 1 coronary perforation (0.8%), and 3 distal embolizations (2.3%). At the 2-years follow-up, major adverse cardiovascular events occurred in 18.3% of the population.</p><p><strong>Conclusions: </strong>In the context of STEMI, ELCA seems to be an effective device for thrombus dissolution, with adequate technical and procedural success rates. In the present cohort, ELCA use was associated with a low complication rate and favorable long-term outcomes.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 1","pages":"26-31"},"PeriodicalIF":1.5,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sirolimus-coated balloon in young versus old patients with coronary artery disease: a sub-analysis of the EASTBOURNE study.","authors":"Filippo Luca Gurgoglione, Alfonso Ielasi, Irene Bossi, Roberto Latini, Bernardo Cortese","doi":"10.24875/RECICE.M25000532","DOIUrl":"10.24875/RECICE.M25000532","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"272-275"},"PeriodicalIF":1.5,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Post-TAVI management of frail patients: outcomes beyond implantation.","authors":"Sandra Santos-Martínez, Miguel Leiva-Gordillo","doi":"10.24875/RECICE.M25000528","DOIUrl":"10.24875/RECICE.M25000528","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"204-205"},"PeriodicalIF":1.5,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mitral valve-in-valve with severe atrial septum calcification.","authors":"Luis Fernández González, Koldobika García San Román, Juan Carlos Astorga Burgo, Aida Acín Labarta, Juan Pablo Betere Reynolds, Roberto Blanco Mata","doi":"10.24875/RECICE.M25000530","DOIUrl":"https://doi.org/10.24875/RECICE.M25000530","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"124-126"},"PeriodicalIF":1.5,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Occupational exposure to ionizing radiation in pregnant staff. Consensus document of ACI-SEC/ARC-SEC/SERVEI/SENR/SERAM/GeNI.","authors":"Maite Velázquez Martín, Sara Lojo Lendoiro, Nina Soto Flores, Elvira Jiménez Gómez, José María Abadal Villayandre, Tomás Datino, Pedro Navia Álvarez, Eva María González Díaz, Núria Bargalló Alabart, Teresa Bastante Valiente, Dabit Arzamendi Aizpurua, Javier Martín Moreiras, Belén Cid Álvarez","doi":"10.24875/RECICE.M25000522","DOIUrl":"10.24875/RECICE.M25000522","url":null,"abstract":"<p><p>The gender gap in interventional subspecialties is largely due to concerns about occupational radiation exposure. The belief that it is not possible to continue working in cath labs during pregnancy is perceived by many female physicians as a barrier to develop their career or fulfill their motherhood wishes. Many physicians are unaware of the doses of ionizing radiation that are harmful for the fetus, which is the dose received by women who continue to work in cath labs throughout their pregnancies, or do not know the existing regulations. The Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC), the Heart Rhythm Association of the Spanish Society of Cardiology (ARC-SEC), the Spanish Society of Vascular and Interventional Radiology (SERVEI), the Spanish Society of Neuroradiology (SENR), the Spanish Society of Medical Radiology (SERAM), and the Society of the Spanish Group of Interventional Neuroradiology (GeNI) consider it necessary to draft this informative document and joint position paper to provide female physicians with the necessary knowledge to make fully informed decisions on whether to choose an interventional subspecialty or work exposed to ionizing radiation during their pregnancy.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"246-254"},"PeriodicalIF":1.5,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter tricuspid valve replacement: from innovation to real-world clinical integration.","authors":"Cristian Herrera-Flores, Philip Lurz, Karl-Patrik Kresoja","doi":"10.24875/RECICE.M25000531","DOIUrl":"10.24875/RECICE.M25000531","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"202-203"},"PeriodicalIF":1.5,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145709614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial.","authors":"Eva Bernal-Labrador, Rafael Romaguera, Sergio García-Blas, Ander Regueiro, Vicenç Serra, Lluís Asmarats, Helena Tizón-Marcos, Víctor Agudelo, Claudia Scardino, Juan Manuel Casanova-Sandoval, Tania Rodríguez-Gabella, César Jiménez-Méndez, Ángel Pérez-Rivera, Carolina Robles-Gamboa, Ana Ayesta, Pablo Díez-Villanueva, Sergio Raposeiras-Roubín, Ignacio J Amat-Santos, Asunción Esteve-Pastor, Gabriela Veiga-Fernández, Manuel Anguita, David Martí-Sánchez, Nicolás Martínez-Velilla, Laia Cortés, Elena Calvo, Steven Asimbaya, Francesc Formiga, Albert Ariza-Solé","doi":"10.24875/RECICE.M25000519","DOIUrl":"10.24875/RECICE.M25000519","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Although transcatheter aortic valve implantation (TAVI) is the first-line therapy for aortic stenosis (AS), its benefit could be lower (or even disappear) in frail patients. Physical exercise and nutritional support programs are recommended to address frailty. Data on the application of telemedicine strategies in this context is scarce. The objective of this study is to analyze, in older patients with AS undergoing TAVI, the effect of a telematic intervention on the reversal of frailty vs standard of care.</p><p><strong>Methods: </strong>We will be conducting a randomized multicenter study including patients aged ≥ 75 years with severe AS (mean aortic gradient > 40 mmHg, or aortic valve area < 0.8 8 cm² on echocardiogram) with baseline frailty criteria (Short Physical Performance Battery [SPPB ] < 10 and FRAIL scale ≥ 3) undergoing TAVI. Prior to discharge, patients will be randomized to a) a telematic intervention within the first 3 months (nutritional support plus supervised physical exercise plus health education); or b) standard of care. The primary endpoint will be the percentage of patients with frailty reversal (SPPB ≥ 10) at 3 months. The estimated sample size is 206 patients (103 in each arm).</p><p><strong>Conclusions: </strong>The hypothesis of this study is that telematic intervention will allow a higher percentage of frailty reversal at 3 months vs standard of care after TAVI. The results of this study may provide novel information on this approach to frail patients with AS undergoing TAVI.ClinicalTrials.gov registered trial (NCT06742970).</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"223-228"},"PeriodicalIF":1.5,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Spanish cardiac catheterization in congenital heart diseases registry. Fourth official report from the ACI-SEC and the GTH-SECPCC (2023).","authors":"Fernando Ballesteros Tejerizo, Félix Coserría Sánchez, Teresa Bastante, Ana Belén Cid Álvarez, María Álvarez-Fuente, Enrique Balbacid Domingo, Pedro Betrián Blasco, Roberto Blanco Mata, José Ignacio Carrasco, Juan Manuel Carretero Bellón, Juana María Espín López, Marta Flores Fernández, Alfredo Gómez-Jaume, Beatriz Insa Albert, Santiago Jiménez Valero, Luis Andrés Lalaguna, Soledad Ojeda Pineda, Ainhoa Pérez Guerrero, Alejandro Rasines Rodríguez, Joaquín Sánchez Gila, Ricardo Sanz-Ruiz, María Eugenia Vázquez-Álvarez, Juan Ignacio Zabala Argüelles","doi":"10.24875/RECICE.M25000518","DOIUrl":"10.24875/RECICE.M25000518","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>The Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) and the Interventional Working Group of the Spanish Society of Pediatric Cardiology (GTH-SECPCC) present their 2023 annual activity report.</p><p><strong>Methods: </strong>Participation was open to all Spanish centers with cath labs and interventional programs for congenital heart disease. Data was collected online and analyzed by an external company, and members from the ACI-SEC and the GTH-SECPCC.</p><p><strong>Results: </strong>A total of 19 centers participated (15 public and 4 private). Interventional data on adult congenital diseases was contributed to the Registry of Hemodynamics and Interventional Cardiology of the ACI-SEC in 2023 by another 114 hospitals and, then, added to the analysis. A total of 1127 diagnostic studies (1.2% less than 2022) and 3856 interventional cardiac catheterizations (53.7% more than 2022) were registered, 2439 of which (65%) were performed on patients older than 18 years. The most widely performed procedures were foramen ovale closure (1498 cases), atrial septal defect closure (700 cases), transcatheter closure of the patent ductus arteriosus (344 cases) and aortic coarctation (221 cases). The most significant volume increment of cases was associated with ventricular septal defect closure (181%), foramen ovale closure (87%), and aortic coarctation (75%). Interventional procedures were considered successful in 98.3% of the cases, with rates of major procedural complication and in-hospital mortality of 1% and 0.05%, respectively.</p><p><strong>Conclusions: </strong>We present the fourth Spanish cardiac catheterization in congenital heart diseases registry with data from 2023. We observed a significant rise in interventional procedures, notably ventricular septal defect and patent foramen ovale closures. Most interventional techniques continue to demonstrate excellent safety and efficacy outcomes.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"238-245"},"PeriodicalIF":1.5,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility and safety of orbital atherectomy in uncrossable lesions.","authors":"Jeremias Bayón, Ricardo Antonio Mori-Junco, Mária Jusková, María Abellas-Sequeiros, Carlos González-Juanatey","doi":"10.24875/RECICE.M25000524","DOIUrl":"10.24875/RECICE.M25000524","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"7 4","pages":"269-271"},"PeriodicalIF":1.5,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Drug-coated balloons vs drug-eluting stents for the treatment of large native coronary artery disease. Meta-analysis of randomized controlled trials.","authors":"José Antonio Sorolla Romero, Laura Novelli, Jorge Llau García, Sara Huélamo Montoro, Pablo Rubio, José Luis Díez Gil, Luis Martínez-Dolz, Ignacio J Amat Santos, Bernardo Cortese, Fernando Alfonso, Hector M Garcia-Garcia, Jorge Sanz-Sánchez","doi":"10.24875/RECICE.M25000527","DOIUrl":"10.24875/RECICE.M25000527","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>To compare the effects of drug-coated balloon (DCB) vs drug-eluting stent (DES) in patients presenting with de novo large vessel coronary artery disease (CAD).</p><p><strong>Methods: </strong>We conducted a systematic research of randomized controlled trials comparing DCB vs DES in patients with de novo large vessel CAD. Data were pooled by meta-analysis using a random-effects model. The prespecified primary endpoint was target lesion revascularization (TLR).</p><p><strong>Results: </strong>A total of 7 trials enrolling 2961 patients were included. The use of DCB vs DES was associated with a similar risk of TLR (OR, 1.21; 95%CI, 0.44-3.30; I² = 48%), all-cause mortality (OR, 1.56; 95%CI, 0.942.57; I² = 0%), cardiac death (OR, 1.65; 95%CI, 0.90-3.05; I² = 0%), myocardial infarction (OR, 0.97; 95%CI, 0.58-1.61; I² = 0%), major adverse cardiovascular adverse (OR, 1.19; 95%CI, 0.74-1.90; I² = 13.5%) and late lumen loss (standardized mean difference [SMD], -0.35; 95%CI, -0.74 to 0.04; I² = 81.4%). However, the DCB was associated with a higher risk of target vessel revascularization (OR, 2.47; 95%CI, 1.52-4.03; I² = 0%) and smaller minimal lumen diameter during late follow-up (SMD, -0.36; 95%CI, -0.56 to -0.15; I² = 34.5%). Nevertheless, prediction intervals included the value of no difference for both outcomes.</p><p><strong>Conclusions: </strong>In patients with de novo large vessel CAD the use of DCB vs DES is associated with a similar risk of TLR. However, the DES achieves better late angiographic results.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 1","pages":"8-16"},"PeriodicalIF":1.5,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}